SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-028816
Filing Date
2024-02-28
Accepted
2024-02-28 17:31:47
Documents
5
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 tm246125d1_s8.htm S-8 46999
2 EXHIBIT 5.1 tm246125d1_ex5-1.htm EX-5.1 14511
3 EXHIBIT 23.1 tm246125d1_ex23-1.htm EX-23.1 2591
4 EX-FILING FEES tm246125d1_ex-filingfees.htm EX-FILING FEES 17707
5 GRAPHIC tm246125d1_ex5-1img001.jpg GRAPHIC 17396
  Complete submission text file 0001104659-24-028816.txt   107000
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277480 | Film No.: 24697330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)